Skip to main content
. 2020 Apr 22;17:124. doi: 10.1186/s12974-020-01813-5

Fig. 1.

Fig. 1

Plasma biomarker levels in the CADASIL and control groups. NfL, GFAP, and UCHL1 levels were higher in the patients than in the control group. NfL was higher in the patients with stroke (IS only or ever ICH). GFAP was the highest in the patients with ICH. *p < 0.05, **p < 0.01